文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

意大利伦巴第地区1591例SARS-CoV-2感染ICU患者的基线特征与结局

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
PubMed 文献 · JAMA · 2020-01-01
一句话结论意大利伦巴第72家医院ICU收治的1591例实验室确诊COVID-19患者中,99%需要呼吸支持、88%接受机械通气,ICU死亡率26%,年龄≥64岁者死亡率高于≤63岁者(36% vs 15%)。

该研究为回顾性病例系列,纳入2020年2月20日至3月18日意大利伦巴第COVID-19 ICU网络72家医院连续收治的1591例实验室确诊COVID-19 ICU患者,由协调中心通过电话记录电子工作表收集数据,最终随访日期为2020年3月25日。患者中位年龄63岁(IQR 56-70),82%为男性;有合并症数据者中68%至少有一种合并症,49%有高血压。有呼吸支持数据的1300例中99%需要呼吸支持,其中88%接受机械通气、11%接受无创通气;中位PEEP为14 cm H2O,89%患者Fio2大于50%,中位PaO2/Fio2为160。截至2020年3月25日,有ICU转归数据的1581例中58%仍在ICU、16%转出ICU、26%在ICU死亡;年龄≥64岁患者死亡率高于≤63岁患者(36% vs 15%)。

要点

  • 1591例实验室确诊COVID-19 ICU患者中82%为男性,中位年龄63岁(IQR 56-70)。
  • 有呼吸支持数据的1300例中99%需要呼吸支持,88%接受机械通气,11%接受无创通气。
  • 中位PEEP为14 cm H2O(IQR 12-16),89%患者Fio2大于50%,中位PaO2/Fio2为160(IQR 114-220)。
  • 截至2020年3月25日,有ICU转归数据的1581例中26%在ICU死亡,58%仍在ICU,16%转出ICU。
  • 年龄≥64岁患者ICU死亡率高于≤63岁患者(36% vs 15%,差异21%[95%CI 17%-26%],P<.001)。

适用人群与场景

  • 2020年2月20日至3月18日意大利伦巴第COVID-19 ICU网络72家医院连续收治的实验室确诊COVID-19并转诊至ICU的成人患者,共1591例。
  • SARS-CoV-2感染经鼻咽拭子实时逆转录聚合酶链反应(RT-PCR)检测确诊。

研究设计与关键结果

  • 研究类型为回顾性病例系列,纳入1591例连续患者,来自意大利伦巴第COVID-19 ICU网络72家医院,数据由协调中心在电话通话中记录于电子工作表。
  • 患者中位年龄63岁(IQR 56-70),1304例(82%)为男性;有合并症数据的1043例中709例(68%)至少有一种合并症,509例(49%)有高血压。
  • 有呼吸支持数据的1300例中1287例(99%[95%CI 98%-99%])需要呼吸支持,其中1150例(88%[95%CI 87%-90%])接受机械通气,137例(11%[95%CI 9%-12%])接受无创通气。
  • 中位PEEP为14 cm H2O(IQR 12-16),89%患者Fio2大于50%,中位PaO2/Fio2为160(IQR 114-220)。
  • 年轻患者(≤63岁,n=503)与老年患者(≥64岁,n=514)中位PEEP无差异:14(IQR 12-15)vs 14(IQR 12-16)cm H2O,中位差0(95%CI 0-0),P=.94。
  • 年轻患者中位Fio2较低:60%(IQR 50%-80%)vs 70%(IQR 50%-80%),中位差-10%(95%CI -14%至6%),P=.006;年轻患者中位PaO2/Fio2较高:163.5(IQR 120-230)vs 156(IQR 110-205),中位差7(95%CI -8至22),P=.02。
  • 高血压患者(n=509)较无高血压患者(n=526)年龄更大(中位66岁[IQR 60-72] vs 62岁[IQR 54-68],P<.001),PaO2/Fio2更低(中位146[IQR 105-214] vs 173[IQR 120-222],中位差-27[95%CI -42至-12],P=.005)。
  • 截至2020年3月25日,有ICU转归数据的1581例中920例(58%[95%CI 56%-61%])仍在ICU,256例(16%[95%CI 14%-18%])转出ICU,405例(26%[95%CI 23%-28%])在ICU死亡;年龄≥64岁患者(n=786)死亡率高于≤63岁患者(n=795)(36% vs 15%,差异21%[95%CI 17%-26%],P<.001)。

证据类型、等级与局限

  • 证据类型:回顾性病例系列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该队列中99%的ICU患者需要呼吸支持、88%接受机械通气,中位PEEP为14 cm H2O、89%患者Fio2大于50%,提示这批COVID-19 ICU患者呼吸衰竭程度重。
  • 年龄≥64岁患者ICU死亡率高于≤63岁患者(36% vs 15%),高血压患者PaO2/Fio2低于无高血压患者(中位146 vs 173)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: In December 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) emerged in China and has spread globally, creating a pandemic. Information about the clinical characteristics of infected patients who require intensive care is limited.

OBJECTIVE: To characterize patients with coronavirus disease 2019 (COVID-19) requiring treatment in an intensive care unit (ICU) in the Lombardy region of Italy.

DESIGN, SETTING, AND PARTICIPANTS: Retrospective case series of 1591 consecutive patients with laboratory-confirmed COVID-19 referred for ICU admission to the coordinator center (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy) of the COVID-19 Lombardy ICU Network and treated at one of the ICUs of the 72 hospitals in this network between February 20 and March 18, 2020. Date of final follow-up was March 25, 2020.

EXPOSURES: SARS-CoV-2 infection confirmed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay of nasal and pharyngeal swabs.

MAIN OUTCOMES AND MEASURES: Demographic and clinical data were collected, including data on clinical management, respiratory failure, and patient mortality. Data were recorded by the coordinator center on an electronic worksheet during telephone calls by the staff of the COVID-19 Lombardy ICU Network.

RESULTS: Of the 1591 patients included in the study, the median (IQR) age was 63 (56-70) years and 1304 (82%) were male. Of the 1043 patients with available data, 709 (68%) had at least 1 comorbidity and 509 (49%) had hypertension. Among 1300 patients with available respiratory support data, 1287 (99% [95% CI, 98%-99%]) needed respiratory support, including 1150 (88% [95% CI, 87%-90%]) who received mechanical ventilation and 137 (11% [95% CI, 9%-12%]) who received noninvasive ventilation. The median positive end-expiratory pressure (PEEP) was 14 (IQR, 12-16) cm H2O, and Fio2 was greater than 50% in 89% of patients. The median Pao2/Fio2 was 160 (IQR, 114-220). The median PEEP level was not different between younger patients (n = 503 aged ≤63 years) and older patients (n = 514 aged ≥64 years) (14 [IQR, 12-15] vs 14 [IQR, 12-16] cm H2O, respectively; median difference, 0 [95% CI, 0-0]; P = .94). Median Fio2 was lower in younger patients: 60% (IQR, 50%-80%) vs 70% (IQR, 50%-80%) (median difference, -10% [95% CI, -14% to 6%]; P = .006), and median Pao2/Fio2 was higher in younger patients: 163.5 (IQR, 120-230) vs 156 (IQR, 110-205) (median difference, 7 [95% CI, -8 to 22]; P = .02). Patients with hypertension (n = 509) were older than those without hypertension (n = 526) (median [IQR] age, 66 years [60-72] vs 62 years [54-68]; P < .001) and had lower Pao2/Fio2 (median [IQR], 146 [105-214] vs 173 [120-222]; median difference, -27 [95% CI, -42 to -12]; P = .005). Among the 1581 patients with ICU disposition data available as of March 25, 2020, 920 patients (58% [95% CI, 56%-61%]) were still in the ICU, 256 (16% [95% CI, 14%-18%]) were discharged from the ICU, and 405 (26% [95% CI, 23%-28%]) had died in the ICU. Older patients (n = 786; age ≥64 years) had higher mortality than younger patients (n = 795; age ≤63 years) (36% vs 15%; difference, 21% [95% CI, 17%-26%]; P < .001).

CONCLUSIONS AND RELEVANCE: In this case series of critically ill patients with laboratory-confirmed COVID-19 admitted to ICUs in Lombardy, Italy, the majority were older men, a large proportion required mechanical ventilation and high levels of PEEP, and ICU mortality was 26%.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020. PMID: 32250385. doi:10.1001/jama.2020.5394

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。